LEoPARD has been awarded an internal grant at maximum value — a full request of $2,000 — by the Vermont Biomedical Research Network (VBRN). Funds received from the grant application — entitled “Quantitative structure-activity relationship (QSAR) study of commercially-available capsaicin, capsaicinoids, capsinoids, and their biosynthetic intermediates: enzymatic and cellular approaches” — is added to a previous … Continue reading LEoPARD awarded internal grant from Vermont Biomedical Research Network
LEoPARD awarded startup supplement funds from Vermont Biomedical Research Network
LEoPARD has been awarded a startup supplement grant at maximum value -- a full request of $10,000 -- by the Vermont Biomedical Research Network (VBRN). Funds received from the grant application -- entitled “Characterizing capsaicinoid and capsinoid mechanisms of insulin sensitization” -- will be added to a startup package already committed by Saint Michael's College. … Continue reading LEoPARD awarded startup supplement funds from Vermont Biomedical Research Network
Our review article “Catechin and other catechol-containing secondary metabolites” is now live at PharmaNutrition
Our recently-accepted review article, “Catechin and other catechol-containing secondary metabolites: Bacterial biotransformation and regulation of carbohydrate metabolism” is now live at PharmaNutrition. The review explores the ubiquity of catechol moieties in endogenous signaling molecules as well as dietary phytochemicals, their prospective biotransformation by gut microbiota and other microorganisms, and the roles that various catechols play … Continue reading Our review article “Catechin and other catechol-containing secondary metabolites” is now live at PharmaNutrition
Laboratory for Evaluation of Pharmacological Agents in Remediation of Disease (LEoPARD) 